Centurion Pharma, which was established in 1979, has been serving the Turkish medicine market by importing products for the treatment of rare diseases encountered in the country, as well as biological, biotechnological and hospital products which are alternatives to today’s modern therapies. The company participates in many collaborations with leading corporations of the world.
Centurion’s R&D facility is located in the Asian part of Istanbul and is focused on 3 strategic development activities: biotechnology/biosimilars, vaccines, and hospital generics. The R&D facility has a total area of 600 sqm works on the development of new molecules and products in co-operation with various Turkish and international scientific and technology institutions.
The company has patents and commercial rights for the majority of its products in Turkey, Middle-East, CIS, North Africa and Balkan Countries.
LATEST issue 4/2018